Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Cymabay Therapeutics Inc. (CBAY)

« Back to company index

CBAY Chatter Timeline

Stock Ticker for CBAY

Most Active Tweeters for CBAY

UserTweets
@TickerReport 5
@AmericanBanking 5
@dailypoliticaln 4
@gcassidy718 4
@BlueBioNow 4

Recent Tweets for CBAY

Gambiste1 @Gambiste1
RT @gcassidy718: $CBAY Looking for any entry here......... ;) 6.27 % change recently https://t.co/FJGm4Lzc67
November 10th 2019, 2:11pm
dailypoliticaln @dailypoliticaln
HC Wainwright Reaffirms “Buy” Rating for CymaBay Therapeutics $CBAY https://t.co/Q1lit4eiJL
November 10th 2019, 1:11pm
ZolmaxNews @ZolmaxNews
HC Wainwright Reaffirms “Buy” Rating for CymaBay Therapeutics $CBAY https://t.co/63Bgqcu7o3
November 10th 2019, 1:11pm
TheMarketsDaily @TheMarketsDaily
Oppenheimer Weighs in on CymaBay Therapeutics Inc’s FY2019 Earnings $CBAY https://t.co/u5h3L8fj9V
November 10th 2019, 7:11am
EnterpriseLeade @EnterpriseLeade
Oppenheimer Weighs in on CymaBay Therapeutics Inc’s FY2019 Earnings $CBAY https://t.co/CVDdOn94nj
November 10th 2019, 6:11am
SwingTradeBot @SwingTradeBot
Recent $CBAY technical alerts: Upper Bollinger Band Walk plus 13 more alerts... https://t.co/iDyxY10h9d
November 9th 2019, 3:11pm
gcassidy718 @gcassidy718
$CBAY Looking for any entry here......... ;) 6.27 % change recently https://t.co/FJGm4Lzc67
November 9th 2019, 1:11pm
dailypoliticaln @dailypoliticaln
FY2019 EPS Estimates for CymaBay Therapeutics Inc Cut by Analyst $CBAY https://t.co/StcnYEDpu5
November 9th 2019, 3:11am
TickerReport @TickerReport
FY2019 EPS Estimates for CymaBay Therapeutics Inc Cut by Analyst $CBAY https://t.co/rGcfIPiQbq
November 9th 2019, 3:11am
ConsumerFeed @ConsumerFeed
CymaBay Therapeutics’ $CBAY “Buy” Rating Reiterated at HC Wainwright https://t.co/4igO7Uh38q
November 9th 2019, 1:11am
TickerReport @TickerReport
HC Wainwright Reiterates Buy Rating for CymaBay Therapeutics $CBAY https://t.co/IXM1VxmjNI
November 9th 2019, 1:11am
WatchlistN @WatchlistN
HC Wainwright Reiterates Buy Rating for CymaBay Therapeutics $CBAY https://t.co/ABIRf0IHA6
November 9th 2019, 1:11am
dailypoliticaln @dailypoliticaln
CymaBay Therapeutics $CBAY Upgraded by ValuEngine to Strong-Buy https://t.co/xyj2QINkeM
November 9th 2019, 12:11am
TickerReport @TickerReport
CymaBay Therapeutics $CBAY Upgraded by ValuEngine to Strong-Buy https://t.co/v1OIISkO0h
November 9th 2019, 12:11am
TranscriptDaily @TranscriptDaily
Oppenheimer Equities Analysts Reduce Earnings Estimates for CymaBay Therapeutics Inc $CBAY https://t.co/FTWmJtRC8l
November 8th 2019, 5:11pm
stocknewstimes @stocknewstimes
Oppenheimer Equities Analysts Reduce Earnings Estimates for CymaBay Therapeutics Inc $CBAY https://t.co/Pc3Wv7QiEg
November 8th 2019, 5:11pm
AmericanBanking @AmericanBanking
Oppenheimer Equities Analysts Reduce Earnings Estimates for CymaBay Therapeutics Inc $CBAY https://t.co/wEn9owqXSF #stocks
November 8th 2019, 5:11pm
SeekingAlpha @SeekingAlpha
$CBAY - CymaBay Therapeutics (CBAY) Investor Presentation - Slideshow. Continue reading: https://t.co/3UxBwfDEvb… https://t.co/ftIqZmV45D
November 8th 2019, 2:11pm
gcassidy718 @gcassidy718
$CBAY blockbuster 4.93 % change recently https://t.co/FJGm4Lzc67
November 8th 2019, 1:11pm
ChartMill @ChartMill
The Current Ratio of $CBAY is much better than the industry average of 5.40. https://t.co/zZIE0kfYBF https://t.co/imCijGQl18
November 7th 2019, 8:11pm
TranscriptDaily @TranscriptDaily
CymaBay Therapeutics $CBAY Raised to “Strong-Buy” at ValuEngine https://t.co/zN6k4NJ5Na
November 7th 2019, 6:11pm
EnterpriseLeade @EnterpriseLeade
CymaBay Therapeutics $CBAY Announces Earnings Results https://t.co/ixYqFnloFc
November 7th 2019, 12:11pm
TranscriptDaily @TranscriptDaily
CymaBay Therapeutics $CBAY Announces Earnings Results, Misses Estimates By $0.01 EPS https://t.co/jh6ejh2skU
November 7th 2019, 12:11pm
AmericanBanking @AmericanBanking
CymaBay Therapeutics’ $CBAY Buy Rating Reaffirmed at HC Wainwright https://t.co/ahRCmHvRFE #stocks
November 7th 2019, 7:11am
OlympiaReport @OlympiaReport
CymaBay Therapeutics $CBAY Announces Earnings Results, Misses Expectations By $0.01 EPS https://t.co/3xJ98kD1no
November 6th 2019, 7:11pm
WeekHerald @WeekHerald
CymaBay Therapeutics $CBAY Releases Quarterly Earnings Results, Misses Estimates By $0.01 EPS https://t.co/H6beweH1q5
November 6th 2019, 6:11pm
dailypoliticaln @dailypoliticaln
CymaBay Therapeutics $CBAY Posts Earnings Results, Misses Expectations By $0.01 EPS https://t.co/tDWzFAlZ7G
November 6th 2019, 6:11pm
ZolmaxNews @ZolmaxNews
CymaBay Therapeutics $CBAY Announces Earnings Results https://t.co/kr2Ootyd9a
November 6th 2019, 6:11pm
AmericanBanking @AmericanBanking
CymaBay Therapeutics $CBAY Releases Quarterly Earnings Results, Misses Estimates By $0.01 EPS https://t.co/x8NdOJtkPe #stocks
November 6th 2019, 4:11pm
dakotafinancial @dakotafinancial
CymaBay Therapeutics $CBAY Releases Quarterly Earnings Results, Misses Estimates By $0.01 EPS https://t.co/nt7jnqEgU4
November 6th 2019, 4:11pm
NewsQuantified @NewsQuantified
$CBAY CEO Sujal Shah on Q3 2019 Results - Earnings Call Transcript. CBAY's stock shoots +13.58% https://t.co/iioZXzPqo9
November 6th 2019, 1:11pm
BlueBioNow @BlueBioNow
$CBAY new high coming! 11.37 % change recently https://t.co/5FMbJjXg5G
November 6th 2019, 11:11am
SiteFocusHQ @SiteFocusHQ
$CBAY Earnings Intelligence Analysis of recent earnings identified CymaBay Therapeutics, Inc (NASDAQ: CBAY ) busine… https://t.co/q54FzfjT0p
November 6th 2019, 1:11am
SeekingAlpha @SeekingAlpha
$CBAY - Cymabay Therapeutics, Inc. (CBAY) CEO Sujal Shah on Q3 2019 Results - Earnings Call Transcript. Read more a… https://t.co/MPglF5qnxZ
November 6th 2019, 1:11am
ProVesting @ProVesting
$CBAY: CymaBay Therapeutics Inc (CBAY) Q3 2019 Earnings Call Transcript: https://t.co/JMKqNryauJ
November 6th 2019, 1:11am
ZolmaxNews @ZolmaxNews
CymaBay Therapeutics $CBAY Upgraded by ValuEngine to Strong-Buy https://t.co/JQiCAiExrS
November 5th 2019, 10:11pm
gcassidy718 @gcassidy718
$CBAY considerable price movement -4.09 % change recently https://t.co/FJGm4Lzc67
November 5th 2019, 4:11pm
otcdynamics @otcdynamics
$CBAY CymaBay Reports Third Quarter 2019 Financial Results and Provides Corporate Update https://t.co/HOGy9OvsrL
November 5th 2019, 4:11pm
newsfilterio @newsfilterio
CymaBay Reports Third Quarter 2019 Financial Results and Provides Corporate Update $CBAY https://t.co/QnxwMjxfSE
November 5th 2019, 4:11pm
MarketCurrents @MarketCurrents
$CBAY - CymaBay Therapeutics EPS misses by $0.01 https://t.co/ZMozlg1TX2
November 5th 2019, 4:11pm
BlueBioNow @BlueBioNow
$CBAY is winning today. : ) 5.24 % change recently https://t.co/5FMbJjXg5G
November 5th 2019, 5:11am
stocknewstimes @stocknewstimes
CymaBay Therapeutics $CBAY Rating Increased to Strong-Buy at ValuEngine https://t.co/YNy9MSglQG
November 4th 2019, 10:11pm
TheMarketsDaily @TheMarketsDaily
CymaBay Therapeutics $CBAY Rating Increased to Strong-Buy at ValuEngine https://t.co/IM75DgUNG9
November 4th 2019, 10:11pm
realmaciej @realmaciej
RT @MaisaCorp: $CBAY achieved the targeted 240- patient enrollment goal for ENHANCE, a global Phase 3 study evaluating seladelpar for patie…
November 4th 2019, 7:11pm
MaisaCorp @MaisaCorp
$CBAY achieved the targeted 240- patient enrollment goal for ENHANCE, a global Phase 3 study evaluating seladelpar… https://t.co/fq1wHlE0LE
November 4th 2019, 7:11pm
bbnsnews @bbnsnews
CymaBay Therapeutics $CBAY to Release Quarterly Earnings on Tuesday https://t.co/BMZNyIbpcg
November 4th 2019, 10:11am
bkfViking123 @bkfViking123
RT @BioStocks: $CBAY Reaches Target Enrollment in the ENHANCE Phase 3 Study Evaluating Seladelpar for Primary Biliary Cholangitis https://t…
November 4th 2019, 9:11am
BioStocks @BioStocks
$CBAY Reaches Target Enrollment in the ENHANCE Phase 3 Study Evaluating Seladelpar for Primary Biliary Cholangitis https://t.co/MqIcRq1al3
November 4th 2019, 9:11am
BlueBioNow @BlueBioNow
$CBAY considerable price movement 10.47 % change recently https://t.co/5FMbJjXg5G
November 3rd 2019, 10:11pm
ConsumerFeed @ConsumerFeed
CymaBay Therapeutics $CBAY Set to Announce Quarterly Earnings on Tuesday https://t.co/JxMxaZFpbT
November 3rd 2019, 7:11am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.